It’s easy to spot motivated and engaged employees. They are more productive, they go the extra mile, and they display a sense of ownership in their work.But how do you replicate this culture throughout your organization? How do you encourage…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Panel Backs BI’s Triple Combo After 3rd Try
September 9, 2016
-
BUSINESS Biogen Japan’s Hemophilia Spinoff to Be Up and Running in Early 2017
September 8, 2016
-
ORGANIZATION Kenporen’s Kono Pushes for “Huge Seller” Re-Pricing for Opdivo before 2018
September 7, 2016
-
REGULATORY 6 National Centers Log Generic Use Rate of Average 73.8% in FY2015
September 6, 2016
-
BUSINESS Oncolys to Evaluate Oncolytic Virus in Combination with Immune Checkpoint Inhibitors; Interim Results Expected in 2017
September 5, 2016
-
BUSINESS Otsuka, RIKEN Open Collaborative Research Center to Promote Regenerative Medicine
September 2, 2016
-
BUSINESS Harvoni Outstrips Plavix to Top FY2015 Japan Sales Ranking: Jiho Tally
September 1, 2016
-
REGULATORY Lilly Drops Listing of Taltz amid Pricing Fuss, Wants to Deliver Drug without Restrictions
August 31, 2016
-
REGULATORY MHLW Panel to Discuss Keytruda on Sept. 9, Listing Expected as Early as November
August 30, 2016
-
BUSINESS Sizzling DOAC Market - 4: Companies Aim to Differentiate Their Products through Quality of Information
August 29, 2016
-
BUSINESS Sizzling DOAC Market - 3: Dosage and Administration Vary by Product for PE/DVT Treatment
August 26, 2016
-
REGULATORY Chuikyo Subcommittee Effectively Kicks Off Debates on FY2018 Reform, with Focus on Pricy Meds
August 25, 2016
-
REGULATORY After Taltz Given High Price, MHLW to Push Use of Other Psoriasis Drugs; Revision to Foreign Price Adjustment Eyed
August 25, 2016
-
REGULATORY Chuikyo OKs Praluent, 8 Other APIs for Listing on Aug. 31
August 24, 2016
-
BUSINESS Sizzling DOAC Market - 1: Japan Sales Reaching 140 Billion Yen on 4-Way Fight
August 24, 2016
-
REGULATORY MHLW to Seek Funding to Promote and Support Healthcare Startups in FY2017 Budget Request
August 23, 2016
-
REGULATORY MHLW Set to Defend “High-Level Investment” Credits for Key R&D Tax Break System in FY2017 Reform
August 22, 2016
-
BUSINESS Evidence for Actair Sublingual Tablets “Sets It Apart from Other Therapies”: Shionogi
August 22, 2016
-
BUSINESS Amgen Confident of Getting Handsome Slice of Japan Biosimilar Market: Exec
August 19, 2016
-
INTERVIEW Interview: Ex-Astellas Boss Takenaka Urges Mid-Size Makers to Be More Open to Academia in Pathological Research
August 18, 2016
ページ
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…